WELWYN GARDEN CITY, England--(BUSINESS WIRE)--Novacta Biosystems, the Welwyn Garden City based biotechnology company, has recently completed a €600,000 investment round from new investors including Esperante, existing shareholders Westgate Hall, GEIF Ventures and Oxford Technology 4 VCT as well as a number of other new and existing investors.
